The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma

Carcinogenesis

Volumn 33, Issue 11, 2012, Pages 2276-2282

  Chen, Lingchao ^a,b,c,f   Zhang, Wei ^d,f   Yan, Wei ^d,f   Han, Lei ^a,b,f   Zhang, Kailiang ^a,b,f   Shi, Zhendong ^a,b,f   Zhang, Junxia ^a,b,f   Wang, Yongzhi ^d,f   Li, Yongli ^c,f   Yu, Shizhu ^a,e,f   Pu, Peiyu ^a,b,f   Jiang, Chuanlu ^c,f   Jiang, Tao ^d,f   Kang, Chunsheng ^a,b,f  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Tian Jin Normal University   (China)

^f Chinese Glioma Cooperative Group (CGCG)   (China)

Author keywords

[No Author keywords available]

Indexed keywords

JAGGED1; MICRORNA; MICRORNA 524 5P; TRANSCRIPTION FACTOR HES 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; GENE CONTROL; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GLIOMA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; STRUCTURAL BIOINFORMATICS;

ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; GLIOMA; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84868621391     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs261     Document Type: Article

References (34)

1. Verhaak, R.G., et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17, 98-110.
2. Butowski, N.A. et al. (2006) Diagnosis and treatment of recurrent highgrade astrocytoma. J. Clin. Oncol., 24, 1273-1280.
3. Stupp, R., et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 352, 987-996.
4. Van Meir, E.G. et al. (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA. Cancer J. Clin., 60, 166-193.
5. Stylianou, S. et al. (2006) Aberrant activation of notch signaling in human breast cancer. Cancer Res., 66, 1517-1525.
6. Weng, A.P. et al. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306, 269-271.
7. Oishi, K. et al. (2004) Notch promotes survival of neural precursor cells via mechanisms distinct from those regulating neurogenesis. Dev. Biol., 276, 172-184.
8. Amsen, D. et al. (2004) Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell, 117, 515-526.
9. Morrison, S.J. et al. (2000) Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell, 101, 499-510.
10. Henrique, D. et al. (1997) Maintenance of neuroepithelial progenitor cells by Delta-Notch signalling in the embryonic chick retina. Curr. Biol., 7, 661-670.
11. Gaiano, N., et al. (2000) Radial glial identity is promoted by Notch1 signaling in the murine forebrain. Neuron, 26, 395-404.
12. Al-Hussaini, H. et al. (2011) Notch signaling pathway as a therapeutic target in breast cancer. Mol. Cancer Ther., 10, 9-15.
13. Tammela, T. et al. (2011) VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat. Cell Biol., 13, 1202-1213.
14. Wang, Z. et al. (2006) Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol. Cancer Ther., 5, 483-493.
15. Ponnurangam, S., et al. (2012) Honokiol in combination with radiation targets Notch signaling to inhibit colon cancer stem cells. Mol. Cancer Ther., Apr;11(4):936-72.
16. Sharma, A. et al. (2012) A monoclonal antibody against human Notch1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells. Mol. Cancer Ther., 11, 77-86.
17. Koduru, S. et al. (2010) Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis. Mol. Cancer Ther., 9, 202-210.
18. Xu, P. et al. (2010) The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo. J. Neurooncol., 97, 41-51.
19. Xu, P. et al. (2009) Differential expression of Notch family members in astrocytomas and medulloblastomas. Pathol. Oncol. Res., 15, 703-710.
20. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
21. Lewis, B.P. et al. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
22. Bandyopadhyay, S. et al. (2010) Development of the human cancer micro-RNA network. Silence, 1, 6.
23. Calin, G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
24. Zhou, X. et al. (2010) Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab. Invest., 90, 144-155.
25. Koch, U. et al. (2007) Notch and cancer: a double-edged sword. Cell. Mol. Life Sci., 64, 2746-2762.
26. Artavanis-Tsakonas, S. et al. (1999) Notch signaling: cell fate control and signal integration in development. Science, 284, 770-776.
27. Gaiano, N. et al. (2002) The role of notch in promoting glial and neural stem cell fates. Annu. Rev. Neurosci., 25, 471-490.
28. Poellinger, L. et al. (2008) Modulating Notch signaling by pathwayintrinsic and pathway-extrinsic mechanisms. Curr. Opin. Genet. Dev., 18, 449-454.
29. Rehman, A.O. et al. (2006) Notch signaling in the regulation of tumor angiogenesis. Trends Cell Biol., 16, 293-300.
30. Guessous, F. et al. (2010) microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle, 9, 1031-1036.
31. Li, Y. et al. (2009) MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res., 69, 7569-7576.
32. Stockhausen, M.T. et al. (2010) The functional role of Notch signaling in human gliomas. Neuro-oncology, 12, 199-211.
33. Pang, R.T. et al. (2010) MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis, 31, 1037-1044.
34. Garzia, L. et al. (2009) MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS ONE, 4, e4998.